Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
Year: 2001
Type: article
Authors: Gregory A Wiseman, Christine A White, Richard B Sparks, William D Erwin, Donald A Podoloff, Dominick Lamonica, Nancy L Bartlett, J Anthony Parker, William L Dunn, Stewart M Spies, Richard Belanger, Thomas E Witzig, Bryan R Leigh
Institutions: Mayo Clinic, Biogen (United States), Oak Ridge Associated Universities, Oak Ridge National Laboratory, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, The University of Texas MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center, Washington University in St. Louis, Harvard University
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2054823183